Lindbrook Capital’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$13.7K Buy
614
+38
+7% +$818 ﹤0.01% 1522
2024
Q4
$9.94K Sell
576
-14
-2% -$217 ﹤0.01% 1651
2024
Q3
$9.89K Buy
590
+75
+15% +$1.8K ﹤0.01% 1687
2024
Q2
$14.7K Buy
515
+96
+23% +$2.89K ﹤0.01% 1415
2024
Q1
$16K Buy
419
+92
+28% +$3.48K ﹤0.01% 1330
2023
Q4
$12.2K Buy
327
+51
+18% +$1.71K ﹤0.01% 1439
2023
Q3
$9.39K Sell
276
-38
-12% -$1.44K ﹤0.01% 1451
2023
Q2
$12.4K Buy
314
+14
+5% +$505 ﹤0.01% 1339
2023
Q1
$9.64K Sell
300
-83
-22% -$2.74K ﹤0.01% 1480
2022
Q4
$11.9K Sell
383
-66
-15% -$2.39K ﹤0.01% 1345
2022
Q3
$17K Buy
449
+39
+10% +$1.46K ﹤0.01% 1075
2022
Q2
$12K Sell
410
-207
-34% -$7.41K ﹤0.01% 1190
2022
Q1
$32K Sell
617
-1,386
-69% -$59.4K ﹤0.01% 841
2021
Q4
$101K Buy
+2,003
New +$112K 0.02% 489

Other funds holding PGNY

Lindbrook Capital's PGNY Position: Q1 2025 in Review

Lindbrook Capital increased its Progyny (PGNY) stake by 6.6% in Q1 2025, buying an estimated $818 and bringing the position to 614 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1522.

Lindbrook Capital first reported a position in PGNY in Q4 2021 and has held it in 14 quarters since. The position peaked at $101K in Q4 2021. 288 funds tracked by Wall St. Rank hold PGNY as of Q1 2025.

  • Lindbrook Capital held 614 shares of Progyny worth $13.7K as of Q1 2025.
  • Lindbrook Capital bought 38 Progyny shares in Q1 2025, an estimated $818.
  • Progyny made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1522 holding.
  • Lindbrook Capital first reported a position in Progyny in Q4 2021 and has held it in 14 quarters since.
  • Lindbrook Capital's Progyny position peaked at $101K in Q4 2021.
  • 288 funds tracked by Wall St. Rank held Progyny as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.